International Stem Cell (ISCO) Long-Term Investments (2015 - 2026)
International Stem Cell's (ISCO) quarterly Long-Term Investments came in at $256000.0 in Q2 2026, down 3.76% year-over-year from $266000.0 in Q2 2025, and up 11.79% quarter-over-quarter from $229000.0 in Q4 2025.
Powered by 
Analysis
International Stem Cell (ISCO) Long-Term Investments (2015 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Long-Term Investments for 12 consecutive years, with $256000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Investments fell 3.76% year-over-year to $256000.0 in Q2 2026; TTM through Jun 2026 was $256000.0, a 3.76% decrease from a year earlier, with the FY2025 full-year figure at $229000.0, down 9.13% from the prior year.
- Long-Term Investments was $256000.0 for Q2 2026 at International Stem Cell, up from $229000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $390000.0 in Q1 2022 and troughed at $223000.0 in Q3 2024.
- A 5-year average of $281411.8 and a median of $266000.0 in 2023 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments decreased 26.38% in 2024 and advanced 10.83% in 2025, its largest moves.
- Over 5 years, Long-Term Investments stood at $286000.0 in 2022, then dropped by 6.99% to $266000.0 in 2023, then fell by 5.26% to $252000.0 in 2024, then slipped by 9.13% to $229000.0 in 2025, then grew by 11.79% to $256000.0 in 2026.
- The last three Long-Term Investments figures came in at $256000.0 (Q2 2026), $229000.0 (Q4 2025), and $239000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 257.29 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 30.27 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 490,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 362.70 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 102.10 Mn |
| 10 | International Stem Cell | 2.84 Mn | 1.75 Mn | 1.46 Mn | 256,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256,000.00 |
| Dec 31, 2025 | 229,000.00 |
| Sep 30, 2025 | 239,000.00 |
| Jun 30, 2025 | 266,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 240,000.00 |
| Mar 31, 2024 | 260,000.00 |
| Dec 31, 2023 | 266,000.00 |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | 326,000.00 |
| Mar 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 286,000.00 |
| Sep 30, 2022 | 369,000.00 |
| Jun 30, 2022 | 359,000.00 |
| Mar 31, 2022 | 390,000.00 |
| Dec 31, 2021 | 372,000.00 |
| Sep 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 363,000.00 |